{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:16:03Z","timestamp":1788419763844,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Physicians and neurotechnology companies each play a critical collaborative role when integrating neurotechnology into clinical practice. Physicians serve as gatekeepers and decision-makers in adopting neurotechnology, while companies often support the development, training, and maintenance of these devices. Relationships with industry require physicians to navigate complex clinical, ethical, and technological factors that affect their clinical roles. To understand physicians\u2019 relationships with neurotechnology companies and facilitate responsible collaborations between the two, this study investigated physicians\u2019 perspectives on these relationships and their influence on clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Physicians (\n                      <jats:italic>N<\/jats:italic>\n                      = 13) using neurotechnology to treat patients participated in a semi-structured interview exploring perspectives on neurotechnology companies and how these relationships affect their decision-making and approach to patient care. Interviews were recorded, transcribed, and coded using an inductive thematic approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Physicians found their relationships with neurotechnology companies both beneficial and essential for device implementation in patient care. However, physicians acknowledged tensions that can arise when financial motivations of companies influence patient care. Company-sponsored research, events, marketing materials, and aggressive sales practices were viewed as potential sources of undue influence. But physicians also noted that reliable customer support, strong evidence of device safety and efficacy, streamlined implementation workflows, and devices that fit patients\u2019 needs were all positive factors. Physicians expressed frustration about lack of transparency from companies regarding device troubleshooting and data sharing, high turnover in customer support or company leadership roles, and discontinuation of essential products or services. Additionally, physicians noted serious ramifications to patient care when a company discontinues a device or goes out of business without clear resolutions. Finally, physicians shared strategies for promoting objective clinical decision-making when working with companies, such as prioritizing patient wellbeing, using independent data sources, and conferring with colleagues to inform decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Relationships between physicians and neurotechnology companies are essential for connecting devices to patient treatment. Physicians, companies, and hospitals all play a role in balancing financial motivations that intersect with patient care priorities. Findings from this study underscore the importance of ensuring that neurotechnological advancements prioritize patient well-being amid the complex partnerships between companies and physicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2026.1926799","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:40:45Z","timestamp":1788417645000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["How physician relationships with neurotechnology companies impact clinical practice: interviews with physicians"],"prefix":"10.3389","volume":"20","author":[{"given":"Meredith V.","family":"Parsons","sequence":"first","affiliation":[{"name":"Bioethics Research Center, Division of General Internal Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Mwobobia","sequence":"additional","affiliation":[{"name":"Bioethics Research Center, Division of General Internal Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Bioethics Research Center, Division of General Internal Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kudom-Agyemang","sequence":"additional","affiliation":[{"name":"Bioethics Research Center, Division of General Internal Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"DuBois","sequence":"additional","affiliation":[{"name":"Bioethics Research Center, Division of General Internal Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"McIntosh","sequence":"additional","affiliation":[{"name":"Bioethics Research Center, Division of General Internal Medicine, Washington University School of Medicine","place":["St. Louis, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","unstructured":"Physician relationships with industry.\n          \n          403\n          404\n          \n            \n              Breault\n              J. L.\n            \n          \n          Ochsner. J.\n          15\n          2015"},{"key":"B2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/ipj.ipj_88_18","article-title":"Transcranial magnetic stimulation: A review of its evolution and current applications.","volume":"27","author":"Chail","year":"2018","journal-title":"Ind. Psychiatry. J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1377\/hlthaff.27.6.1532","article-title":"Physician-industry cooperation in the medical device industry.","volume":"27","author":"Chatterji","year":"2008","journal-title":"Health Aff"},{"key":"B4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12152-024-09549-2","article-title":"What happens after a neural implant study? Neuroethics expert workshop on post-trial obligations.","volume":"17","author":"Dasgupta","year":"2024","journal-title":"Neuroethics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/03080188.2020.1840223","article-title":"Clinical translation of computational brain models: Understanding the salience of trust in clinician\u2013researcher relationships.","volume":"46","author":"Datta Burton","year":"2021","journal-title":"Interdiscip. Sci. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/ner.12906","article-title":"Heart and brain diseases: Two different worlds.","volume":"22","author":"Dones","year":"2019","journal-title":"Neuromodulation"},{"key":"B7","volume-title":"Abandoned: The Human Cost of Neurotechnology Failure.","author":"Drew","year":"2022"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15265161.2017.1314043","article-title":"Physician decision making and the web of influence.","volume":"17","author":"DuBois","year":"2017","journal-title":"Am. J. Bioeth"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.mayocp.2017.05.005","article-title":"Neurostimulation devices for the treatment of neurologic disorders.","volume":"92","author":"Edwards","year":"2017","journal-title":"Mayo. Clin. Proc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.brs.2021.08.021","article-title":"Neuromodulatory treatments for psychiatric disease: A comprehensive survey of the clinical trial landscape.","volume":"14","author":"Elias","year":"2021","journal-title":"Brain Stimul"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough? An experiment with data saturation and variability.","volume":"18","author":"Guest","year":"2006","journal-title":"Field. Methods."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0232076","DOI":"10.1371\/journal.pone.0232076","article-title":"A simple method to assess and report thematic saturation in qualitative research.","volume":"15","author":"Guest","year":"2020","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/ijerph22050811","article-title":"A horizon scan of neurotechnology innovations.","volume":"22","author":"Haston","year":"2025","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/15265161.2020.1782643","article-title":"Ethically problematic medical device representation.","volume":"20","author":"Illes","year":"2020","journal-title":"Am. J. Bioeth"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1161\/01.cir.97.19.1978","article-title":"Cardiac pacing, 1960-1985: A quarter century of medical and industrial innovation.","volume":"97","author":"Jeffrey","year":"1998","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/hast.515","article-title":"Engineering the brain: Ethical issues and the introduction of neural devices.","volume":"45","author":"Klein","year":"2015","journal-title":"Hastings Cent. Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1007\/s11606-021-06657-0","article-title":"A ray of sunshine: Transparency in physician-industry relationships is not enough.","volume":"36","author":"Lexchin","year":"2021","journal-title":"J. Gen. Intern. Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mar.21146","article-title":"Through the looking glass: The factors that influence consumer trust and distrust in brands.","volume":"35","author":"Mal","year":"2018","journal-title":"Psychol. Mark."},{"key":"B19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1472-6947-12-74","article-title":"Integrating the results of user research into medical device development: Insights from a case study.","volume":"12","author":"Martin","year":"2012","journal-title":"BMC Med. Inform. Decis. Mak"},{"key":"B20","volume-title":"Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project.","author":"McIntosh","year":"2022"},{"key":"B21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/21507740.2020.1778122","article-title":"From research to clinical practice: Ethical issues with neurotechnology and industry relationships.","volume":"11","author":"McIntosh","year":"2020","journal-title":"AJOB Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/21507740.2021.2001083","article-title":"Ethical Challenges in the Commercialization of Neurotechnology: Contending with Competing Priorities.","volume":"13","author":"McIntosh","year":"2022","journal-title":"AJOB Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101950","DOI":"10.1016\/j.leaqua.2026.101950","article-title":"Defining, assessing, and reporting saturation in qualitative research: Review and recommendations.","volume":"37","author":"Moore","year":"2026","journal-title":"Leadersh. Q."},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/JCE.0000000000000046","article-title":"Improving patient safety through collaboration between clinical staff and engineering staff in hospitals.","volume":"39","author":"Morschauser","year":"2014","journal-title":"J. Clin. Eng."},{"key":"B25","volume-title":"Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants), End User (Hospitals, Clinics, Diagnostic Centres, Ambulatory Surgical Centres), and Region 2024\u20132032.","year":"2023"},{"key":"B26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.37745\/bjmas.2022.0419","article-title":"Types of purposive sampling techniques with their examples and application in qualitative research studies.","volume":"5","author":"Nyimbili","year":"2024","journal-title":"Br. J. Multidiscip. Adv. Studies."},{"key":"B27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/03091902.2022.2089255","article-title":"Managing interorganisational collaborations to develop medical technologies: The contribution of interpersonal relationships.","volume":"46","author":"Olubajo","year":"2022","journal-title":"J. Med. Eng. Technol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0330367","DOI":"10.1371\/journal.pone.0330367","article-title":"Ethical implications of neurotechnology in industry-academia partnerships: Insights from patient and research participant interviews.","volume":"20","author":"Parsons","year":"2025","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12152-025-09618-0","article-title":"Conflicting Interests and new frontiers: A role for virtue ethics in cutting edge brain research with humans.","volume":"18","author":"Peabody Smith","year":"2025","journal-title":"Neuroethics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1752-8062.2010.00248.x","article-title":"Successfully accelerating translational research at an academic medical center: The university of michigan-coulter translational research partnership program.","volume":"3","author":"Pienta","year":"2010","journal-title":"Clin. Transl. Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1055\/s-0038-1668081","article-title":"ethical issues pertaining to conflicts of interest between neurologists and the pharmaceutical and medical device industries.","volume":"38","author":"Robbins","year":"2018","journal-title":"Semin. Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1212\/WNL.0000000000008067","article-title":"Scope and nature of financial conflicts of interest between neurologists and industry: 2013-2016.","volume":"93","author":"Robbins","year":"2019","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"S3037","DOI":"10.4103\/jpbs.jpbs_1005_24","article-title":"Exploring the impact of brain-computer interfaces on health care: Innovations, challenges, and future prospects: A review article.","volume":"16","author":"Sah","year":"2024","journal-title":"J. Pharm. Bioallied. Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/jlme.12076","article-title":"Physicians under the influence: Social psychology and industry marketing strategies.","volume":"41","author":"Sah","year":"2013","journal-title":"J. Law. Med. Ethics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12911-016-0377-1","article-title":"Cognitive biases associated with medical decisions: A systematic review.","volume":"16","author":"Saposnik","year":"2016","journal-title":"BMC Med. Inform. Decis. Mak"},{"key":"B36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12028-023-01924-w","article-title":"Brain-computer interfaces for communication in patients with disorders of consciousness: A gap analysis and scientific roadmap.","volume":"41","author":"Schiff","year":"2024","journal-title":"Neurocrit. Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1017\/S0266462307051677","article-title":"Benefits of and barriers to involving users in medical device technology development and evaluation.","volume":"23","author":"Shah","year":"2007","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1000352","DOI":"10.1371\/journal.pmed.1000352","article-title":"Information from pharmaceutical companies and the quality, quantity, and cost of physicians\u2019 prescribing: A systematic review.","volume":"7","author":"Spurling","year":"2010","journal-title":"PLoS Med"},{"key":"B39","volume-title":"Qualitative Methods in Public Health: A Field Guide for Applied Research","author":"Tolley","year":"2016"},{"key":"B40","volume-title":"Conflict of Interest in Medical Research, Education, and Practice.","year":"2009"},{"key":"B41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nhs.12048","article-title":"Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study.","volume":"15","author":"Vaismoradi","year":"2013","journal-title":"Nurs. Health Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/swr\/svy026","article-title":"An examination of the sufficiency of small qualitative samples.","volume":"43","author":"Young","year":"2019","journal-title":"Soc. Work Res."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1926799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:40:47Z","timestamp":1788417647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1926799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":42,"alternative-id":["10.3389\/fnins.2026.1926799"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1926799","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1926799"}}